Quadrature Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-33,686
Closed -$1.2M 1274
2023
Q1
$1.2M Sell
33,686
-80,358
-70% -$2.92M 0.03% 378
2022
Q4
$4.18M Buy
114,044
+78,443
+220% +$3.1M 0.12% 164
2022
Q3
$1.68M Buy
+35,601
New +$2.3M 0.05% 285
2021
Q1
Sell
-13,198
Closed -$899K 1210
2020
Q4
$899K Buy
+13,198
New +$823K 0.04% 336
2018
Q2
Sell
-6,562
Closed -$233K 780
2018
Q1
$233K Buy
+6,562
New +$257K 0.02% 529
2016
Q4
Sell
-5,389
Closed -$240K 836
2016
Q3
$240K Buy
+5,389
New +$234K 0.02% 490

Other funds holding SYNH

Quadrature Capital's SYNH Position: Q2 2023 in Review

Quadrature Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 33,686 shares — an estimated $1.2M sold.

Quadrature Capital first reported a position in SYNH in Q3 2016 and held it in 6 quarters. The position peaked at $4.18M in Q4 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Quadrature Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Quadrature Capital sold 33,686 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $1.2M.
  • Quadrature Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 6 quarters.
  • Quadrature Capital's Syneos Health, Inc. Class A Common Stock position peaked at $4.18M in Q4 2022.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Quadrature Capital's 13F filing for Q2 2023, filed 14 Aug 2023.